CHINA HEALTH (00673) cancels 40.63 million share purchase rights.
China Health Group (00673) announced that on February 13, 2026, in accordance with the terms of the plan, the board of directors announced the cancellation of the stock purchase rights by issuing written notices to the grantees, exercising their discretion to cancel all 40,638,000 stock purchase rights granted on February 2, 2026 and not validly exercised by any grantees.
China Health (00673) announced that on February 13, 2026, in accordance with the terms of the plan, the board of directors announced the cancellation of the stock options by written notice to the grantee, exercising its discretion to cancel in full the 40.638 million stock options granted on February 2, 2026, which were not effectively exercised by any grantee.
As the cancelled stock options will be considered as utilized, the available number of shares for future grants under the plan authorization limit and individual limit for service providers will be maintained at approximately 7.2615 million shares and 4.7899 million shares, respectively.
Related Articles

MEDBOT-B(02252): The Stock Exchange approves the listing of the company's H-shares for full circulation.

ALMANA (08186): Executive Director Zhang Zhirong appointed as Joint Chairman.

CHINA CBM(08270): Chang Jian Resigns as Executive Director
MEDBOT-B(02252): The Stock Exchange approves the listing of the company's H-shares for full circulation.

ALMANA (08186): Executive Director Zhang Zhirong appointed as Joint Chairman.

CHINA CBM(08270): Chang Jian Resigns as Executive Director

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


